Product Information
INCASSIA 0.35 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0943 per EA under NDC 65862092585. Its NADAC has been published 378 times since Apr 3, 2019.
Strength
.35 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862092585
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
NORETHINDRONEApproval Type
Generic (ANDA)
FDA Application
ANDA207304On Market Since
9/23/2016
Pharmacological Classes
Price Statistics
The NADAC for INCASSIA 0.35 MG TABLET has been published 378 times since Apr 3, 2019, and over the history we have for it it has declined 35.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0943 per EA |
|---|---|
| All-time high | $0.2295 (Apr 14, 2021) |
| All-time low | $0.0691 (Nov 20, 2024) |
| 52-week high | $0.0945 |
| 52-week low | $0.0849 |
| Median price | $0.1489 |
| Average price | $0.1510 |
| Largest weekly change | +43.4% (Aug 21, 2024) |
| Weeks tracked | 378 |
| Tracking since | Apr 3, 2019 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of INCASSIA 0.35 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INCASSIA 0.35 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0943 per EA (NDC 65862092585), effective Jun 24, 2026.
How has the price of INCASSIA 0.35 MG TABLET changed over time?
Over the history we have for it, the NADAC for INCASSIA 0.35 MG TABLET has declined 35.2%. It has been tracked across 378 weekly CMS publications since Apr 3, 2019.
What are the highest and lowest recorded NADAC prices for INCASSIA 0.35 MG TABLET?
Since Apr 3, 2019, the NADAC for INCASSIA 0.35 MG TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.2295 (Apr 14, 2021), with a median of $0.1489 per EA.
Are there cheaper alternatives to INCASSIA 0.35 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as INCASSIA 0.35 MG TABLET, but none are currently priced below it.
Who manufactures INCASSIA 0.35 MG TABLET?
INCASSIA 0.35 MG TABLET (NDC 65862092585) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification